Report Buyer Logo
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report providing an overview of the biggest sector of the Indian biotechnology market, biopharma.
The report “Booming Biotech Market in India”, available at http://www.reportbuyer.com/
According to the study, the total biopharma industry - consisting of therapeutics, vaccines, diagnostics, and other products such as statins - recorded a massive 26.9% growth in fiscal 2007 and continues to be the largest contributor to the overall biotech market in India.
The impressive performance of the Indian biopharma sector is the result of the strongly growing vaccine business, which accounted for about 50% of the total biopharma business in fiscal 2007. The vaccine business will remain dynamic in future, taking the overall biopharma market up. In addition to this, driven by a rise in chronic diseases and investments in the healthcare infrastructure, diagnostics and therapeutics business is also anticipated to have a bright future. The biopharma sector will further benefit from the fact that India is forecast to become a key biogenerics supplier to the developed world in near future.
The report is an exhaustive study of the thriving biotech market in the emerging economy, India. It provides prudent research and analysis supported by statistical facts and figures on parameters that make up the structure of the Indian biotech market. It describes the market landscape and gives comprehensive information on market size, structure, key segments, domestic consumption, exports, investment, and market share of key players.
“Booming Biotech Market in India” is available from Report Buyer. For more information, visit: http://www.reportbuyer.com/
Report Buyer product ID: RCS00434
Photo:
http://www.prlog.org/
